Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

End-of-day quote Wiener Boerse 2026-09-10			5-day change	1st Jan Change
57.40 ^EUR	-0.43%		-2.79%	-9.32%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
ELI LILLY AND COMPANY	994B		A
JOHNSON & JOHNSON	640B	-	BBB	-	-
ABBVIE INC.	454B		AAA		-
ROCHE HOLDING AG	337B		AA
NOVARTIS AG	261B		AAA
ASTRAZENECA PLC	246B		A
AMGEN INC.	204B		A
NOVO NORDISK A/S	190B		BBB
GILEAD SCIENCES, INC.	178B		AA
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	131B		AA
BRISTOL-MYERS SQUIBB COMPANY	130B		A
SANOFI	102B		A
GSK PLC	95.94B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	68.8B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.91B		AA
BAYER AG	54.92B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	43.22B		-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	41.9B		AA
Average	231B		AA
Weighted average by Cap.			AA